文献速递临床试验与 GCP流行病学与生物统计

大型随机对照试验试验后随访方法:一项系统综述

Post-trial follow-up methodology in large randomised controlled trials: a systematic review.
PubMed 文献 · Trials · 2018-05-30

该研究遵循PRISMA指南系统检索五个文献数据库和一个试验注册库,定性比较2006年3月至2017年4月发表的大型随机对照试验(超过1000名成人参与者)的试验后随访方法,共纳入65项有试验后随访的试验。多数试验采用一种以上随访类型,参与者保留率与随访类型无关联证据,数据链接成本最低。

要点

  • 试验后随访可检测持续或增强的获益及迟发不良效应。
  • 数据链接是最经济的试验后随访方法。
  • 参与者保留率与随访类型无关联证据。

核心结论

  • 试验后随访期间采集的数据可为试验增加科学价值,但存在后勤和财务障碍。
  • 电子注册和记录的数据链接是一种成本效益高的方法,可提供一系列终点数据。

研究设计与样本

  • 遵循PRISMA指南的系统综述,检索五个文献数据库(包括Medline和Cochrane Library)和一个试验注册库。
  • 评估2006年3月至2017年4月发表的所有大型随机对照试验(超过1000名成人参与者),两名评价者筛选和提取数据,论文核对一致率超过95%。
  • 使用Cochrane偏倚风险工具评估试验偏倚。

主要发现

  • 大多数试验使用一种以上类型的随访。
  • 没有证据表明试验后随访期间参与者保留率与所用随访类型之间存在关联。
  • 试验后随访成本差异很大,数据链接最经济。
  • 无法评估试验期间偏倚风险与试验后随访期间失访比例之间的关联。

临床怎么用

  • 试验后随访可检测持续或增强的获益(遗留效应)及迟发不良效应(如癌症发生)。
  • 在可用的情况下,通过电子注册和记录进行数据链接是成本效益高的方法,可提供一系列终点数据。

局限性

  • 无法评估试验期间偏倚风险与试验后随访期间失访比例之间的关联。
  • 存在后勤和财务障碍需要克服。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Randomised controlled clinical trials typically have a relatively brief in-trial follow-up period which can underestimate safety signals and fail to detect long-term hazards, which may take years to appear. Extended follow-up after the scheduled closure of the trial allows detection of both persistent or enhanced beneficial effects following cessation of study treatment (i.e. a legacy effect) and the emergence of possible adverse effects (e.g. development of cancer). METHODS: A systematic review was conducted following PRISMA guidelines to qualitatively compare post-trial follow-up methods used in large randomised controlled trials. Five bibliographic databases, including Medline and the Cochrane Library, and one trial registry were searched. All large randomised controlled trials (more than 1000 adult participants) published from March 2006 to April 2017 were evaluated. Two reviewers screened and extracted data attaining > 95% concordance of papers checked. Assessment of bias in the trials was evaluated using the Cochrane Risk of Bias tool. RESULTS: Fifty-seven thousand three hundred and fifty-two papers were identified and 65 trials which had post-trial follow-up (PTFU) were included in the analysis. The majority of trials used more than one type of follow-up. There was no evidence of an association between the retention rates of participants in the PTFU period and the type of follow-up used. Costs of PTFU varied widely with data linkage being the most economical. It was not possible to assess associations between risk of bias during the in-trial period and proportions lost to follow-up during the PTFU period. DISCUSSION: Data captured during the post-trial follow-up period can add scientific value to a trial. However, there are logistical and financial barriers to overcome. Where available, data linkage via electronic registries and records is a cost-effective method which can provide data on a range of endpoints. SYSTEMATIC REVIEW REGISTRATION: Not applicable for PROSPERO registration.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Llewellyn-Bennett R, Edwards D, Roberts N, et al. Post-trial follow-up methodology in large randomised controlled trials: a systematic review. Trials. 2018. PMID: 29843774. doi:10.1186/s13063-018-2653-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。